4.4 Letter

Rituximab Treatment of Nivolumab-Induced Bullous Pemphigoid

Journal

JAMA DERMATOLOGY
Volume 153, Issue 6, Pages 603-605

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/jamadermatol.2017.0091

Keywords

-

Categories

Funding

  1. Bristol-Myers Squibb International Immuno-Oncology Network (BMS II-ON) Foundation

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available